United States (National)
Not enough data
Cory's coverage revolves around scientific and healthcare topics, with a particular focus on medical research and treatment developments, including cancer, ophthalmology, neurology, and dermatology. Her articles heavily feature expert commentary and data citations.
Given the in-depth nature of her coverage, Cory would likely be most responsive to pitches offering access to experts in these specific fields who can provide unique insights or analysis into recent medical research findings or treatment advancements within the mentioned specialties. Additionally, providing access to new data or exclusive interviews with key figures involved in groundbreaking studies may enhance the appeal of any pitch directed at Cory.
It is clear that she does not have a geographic focus but rather covers global scientific and healthcare developments across various medical disciplines.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Cory Perla, Stephen M. Ansell
ORLANDO — In this video, Stephen M. Ansell, MD, PhD, discusses data from ASH Annual Meeting and Exposition on the use of bispecific antibody combinations in follicular lymphoma and mantle cell lymphoma.
ORLANDO — In this video, Stephen M. Ansell, MD, PhD, discusses findings on the AI-enabled model Lymphovision, which were presented at ASH Annual Meeting and Exposition.
By: Stephen M. Ansell, Cory Perla
ORLANDO — In this video, Stephen M. Ansell, MD, PhD, discusses long-term outcomes from a large prospective cohort study of patients with follicular lymphoma, presented at ASH Annual Meeting and Exposition.
By: Cory Perla, Alissa J. Cooper Md
COPENHAGEN, Denmark — In this Healio video, Alissa J. Cooper, MD, a thoracic oncologist at Dana-Farber Cancer Institute, discusses the TOP trial of osimertinib plus chemotherapy in high-risk patients with non-small cell lung cancer.
By: Heather Biele, Cory Perla, Alissa J. Cooper
Video Player is loading. Play Video Play Mute Current Time Duration Loaded Stream Type LIVE
By: Heather Biele, Cory Perla, Alissa J. Cooper
Video Player is loading. Play Video Play Mute Current Time Duration Loaded Stream Type LIVE
By: Alissa J. Cooper Md, Cory Perla
COPENHAGEN, Denmark — In this Healio video, Alissa J. Cooper, MD, a thoracic oncologist at Dana-Farber Cancer Institute, discusses results from the phase 3 PRESERVE-003 trial, which were presented at European Lung Cancer Congress.
By: Cory Perla, Alissa J. Cooper Md
COPENHAGEN, Denmark — In this Healio video, Alissa J. Cooper, MD, a thoracic oncologist at Dana-Farber Cancer Institute, discusses research the effect of low-dose CT screening in a non-risk-based population.
By: Cory Perla, Balazs Halmos
Video Player is loading. Play Video Play Mute Current Time Duration Loaded Stream Type LIVE
By: Cory Perla, Balazs Halmos
COPENHAGEN, Denmark — In this Healio video, Balazs Halmos, MD, MS, director of thoracic oncology and clinical cancer genomics at Montefiore Einstein Cancer Center, discusses results of the Beamion LUNG-1 trial.
